Scientific Associate - Cardiovascular Biology Group


Allschwil - Basel Area, BL, CH



About Idorsia Pharmaceuticals Ltd

Idorsia Ltd is reaching out for more - We have more ideas, we see more opportunities and we want to help more patients.

In order to achieve this, we will develop Idorsia into one of Europe’s leading biopharmaceutical companies, with a strong scientific core.

Headquartered in Switzerland - a European biotech hub - Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team, a fully-functional research center, and a strong balance sheet – the ideal constellation to bringing R&D efforts to business success.

Idorsia was listed on the SIX Swiss Exchange (ticker symbol: IDIA) in June 2017 and has over 800 highly qualified specialists dedicated to realizing our ambitious targets.


Job Responsibilities

With a significant degree of self-responsibility, the successful candidate will:  

  • Design and perform experiments to support our Cardiovascular drug discovery programs 
  • Develop and routinely use in vitro target- and disease-relevant assay systems required for the characterization of small molecules  
  • Use electronic lab book system to record his/her work 
  • Write draft scientific summary reports 
  • Prepare and give presentations about his/her work to the Lab/Group/Project Team
  • Share with lab colleagues in maintaining an efficient and safe work environment 


Candidate’s Requirements


  • Master or equivalent degree in Cell biology, Molecular biology, Biotechnology or related field with at least two years’ experience in research. 
  • Experience in the pharmaceutical or biotech industry would be an advantage. 
  • Strong experience in the following techniques:  
    • Mammalian cell culture (recombinant and non-recombinant cell lines, primary cells) 
    • Common protein methodologies: Western blotting, ELISA, Luminex 
    • Cell based assays using fluorescent and luminescent readouts 
    • Transfection and transduction techniques to generate recombinant cell lines
    • Receptor signaling assays 
  • Experience in the following techniques would be an asset: 
    • Gene editing technologies (CRISPR) 
    • FACS 
    • High content imaging analysis  
  • Personal skills:
    • Able to perform experiments in a precise and reliable manner 
    • Well-organized multitasker 
    • Detail-oriented with strong problem-solving skills 
    • Fast learner, flexible and good team player 
    • Dynamic, flexible, scientifically curious and willing to learn new skills and techniques
    • Highly motivated to work in an international and interdisciplinary team 
    • Good command of written and spoken English; command of French or German would be an advantage 


What Idorsia offers


  • Exciting opportunities for development and professional growth within our dynamic organization
  • A collaborative and solution-oriented environment where you can make a difference
  • An innovative and open culture in a truly multicultural environment
  • A competitive salary and generous social benefits


Work Location: Allschwil
Country: Switzerland
Business Area: Drug Discovery Biology – Cardiovascular & Fibrosis
Schedule: Fulltime
Job Type: Permanent
Job ID: 2350



If you are interested, please click on apply now.

Please be informed that if you are selected for this position, your employment will be subject to a pre-employment background screening process, of which you will be informed in greater detail in due course.

Idorsia operates a strictly controlled list of preferred recruitment partners. For those partners who have no valid, signed Master Service Agreement in place with Idorsia, please note that all unsolicited resumes, CVs, anonymous profiles, or any other candidate details submitted through our website or to personal e-mail accounts of employees of Idorsia Pharmaceuticals (including any of its subsidiaries, affiliates or related companies) are considered the property of Idorsia Pharmaceuticals and are not subject to payment of any form of introduction, placement or referral fees.